New pills to treat patients with COVID-19 are currently in midstage clinical trials and, if successful, could be ready by
Read more
Home »
Structure-based design of antiviral drug candidates targets SARS-CoV-2 main protease
A team of Chinese scientists has recently developed two novel compounds that inhibit the SARS-CoV-2 main protease (Mpro) and one
Read more
UC San Diego Health launches clinical trial to assess antiviral drug for COVID-19
Physician-scientists at four University of California Health medical centers—UC San Diego Health, UC San Francisco, UC Irvine Health and UC
Read more